SC upholds NPPA's Rs 4.6 crore penalty on Sun Pharma

Sun Pharmaceutical Industries Ltd, the sixth-largest generic pharmaceutical manufacturer in the world, had questioned NPPA's demand notice of 2005 for payment of Rs 4.6 crore "to recover the higher price charged in relation to Roscilox, a brand of a Cloxacillin-based drug formulation, than that fixed by the govt under Drugs (Price Control) Order (DPCO)".

from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/5sNbw29
via